13 C
Wednesday, May 31, 2023

US Allows First Emergency Use of Covid-19 Antibody Drug

Health officials in the United States have allowed emergency use of the first antibody-drug to help the immune system fight Covid-19, reports AP.

This is an experimental approach against the coronavirus in the country. More than 238,000 Americans have been killed due to the virus.

The U.S. Food and Drug Administration on Monday cleared the experimental drug from Eli Lilly. The therapy is still in test to establish its safety and effectiveness. It is similar to a treatment that President Donald Trump took after coronavirus infection last month.

The drug, called bamlanivimab, may help clear the coronavirus sooner, suggests the early results. Additionally, it possibly cut hospitalizations in people with mild to moderate Covid-19, the AP report said.

Earlier, the U.S. government reached an agreement to buy and supply the drug.

The new drug therapy offers a promising new approach to prevent serious disease and death from Coronavirus infection. According to the experts, the infused drugs could serve as a therapeutic bridge to help manage the virus until vaccines are widely available, AP reports.

Read Also: Prominent Singer Kumar Sanu Tests Positive for Covid-19

The laboratory-made drug is versions of antibodies and blood proteins. Which the body creates to help target and eliminate foreign infections. The new therapies are concentrated versions of the antibodies proving most effective against the virus in patients.



Priscilla Presley Net Worth: A Fascinating Career Highlights [2023 Updated]

Listen to the Podcast: Priscilla Presley net worth is a...

Oldest Evidence of Plague Found in Britain by Researchers

The first proof of the epidemic in the nation...

16,000 People Are Evacuated From Canada’s Atlantic Coast Wildfire

Listen to the Podcast: The leader of Nova Scotia asked...

Top 120 Movies2Watch Alternatives for Streaming Movies in 2023

Listen to the Podcast: Are you tired of endlessly scrolling...

Fidelity Says Twitter Is Worth 33% Of Musk’s Purchase Price

Listen to the Podcast: Fidelity recently marked down the value...